Mid-Morning Market Update: Markets Open Higher As Dow Rises Over 100 Points
U.S. stocks opened on a strong note on Friday, after recording sharp losses in the previous session.
Y-mAbs Announces Completion Of Pre-BLA Meeting With FDA For Omburtamab
Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
JP Morgan Maintains Neutral on Y-mAbs Therapeutics, Lowers Price Target to $27
JP Morgan analyst Tessa Romero maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Neutral and lowers the price target from $30 to $27.
JP Morgan Downgrades Y-mAbs Therapeutics to Neutral, Lowers Price Target to $30
JP Morgan analyst Tessa Romero downgrades Y-mAbs Therapeutics (NASDAQ:YMAB) from Overweight to Neutral and lowers the price target from $57 to $30.
81 Biggest Movers From Yesterday
Gainers
Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday.
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.